Literature DB >> 28884347

Effects of levosimendan for perioperative cardiovascular dysfunction in patients receiving cardiac surgery: a meta-analysis with trial sequential analysis.

Chen-Tse Lee1, Yu-Cih Lin2,3, Yu-Chang Yeh1, Ta-Liang Chen2,4, Chien-Yu Chen5,6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28884347     DOI: 10.1007/s00134-017-4927-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.

Authors:  Geert Koster; Jørn Wetterslev; Christian Gluud; Jan G Zijlstra; Thomas W L Scheeren; Iwan C C van der Horst; Frederik Keus
Journal:  Intensive Care Med       Date:  2014-12-18       Impact factor: 17.440

2.  Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.

Authors:  Rajendra H Mehta; Jeffrey D Leimberger; Sean van Diepen; James Meza; Alice Wang; Rachael Jankowich; Robert W Harrison; Douglas Hay; Stephen Fremes; Andra Duncan; Edward G Soltesz; John Luber; Soon Park; Michael Argenziano; Edward Murphy; Randy Marcel; Dimitri Kalavrouziotis; Dave Nagpal; John Bozinovski; Wolfgang Toller; Matthias Heringlake; Shaun G Goodman; Jerrold H Levy; Robert A Harrington; Kevin J Anstrom; John H Alexander
Journal:  N Engl J Med       Date:  2017-03-19       Impact factor: 91.245

Review 3.  Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.

Authors:  Robert W Harrison; Vic Hasselblad; Rajendra H Mehta; Ricardo Levin; Robert A Harrington; John H Alexander
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-09-16       Impact factor: 2.628

4.  Levosimendan for Hemodynamic Support after Cardiac Surgery.

Authors:  Giovanni Landoni; Vladimir V Lomivorotov; Gabriele Alvaro; Rosetta Lobreglio; Antonio Pisano; Fabio Guarracino; Maria G Calabrò; Evgeny V Grigoryev; Valery V Likhvantsev; Marcello F Salgado-Filho; Alessandro Bianchi; Vadim V Pasyuga; Massimo Baiocchi; Federico Pappalardo; Fabrizio Monaco; Vladimir A Boboshko; Marat N Abubakirov; Bruno Amantea; Rosalba Lembo; Luca Brazzi; Luigi Verniero; Pietro Bertini; Anna M Scandroglio; Tiziana Bove; Alessandro Belletti; Maria G Michienzi; Dmitriy L Shukevich; Tatiana S Zabelina; Rinaldo Bellomo; Alberto Zangrillo
Journal:  N Engl J Med       Date:  2017-03-21       Impact factor: 91.245

5.  Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.

Authors:  Ju Yong Lim; Salil V Deo; Abeer Rababa'h; Salah E Altarabsheh; Yang Hyun Cho; Dustin Hang; Michael McGraw; Edwin G Avery; Alan H Markowitz; Soon J Park
Journal:  J Card Surg       Date:  2015-05-19       Impact factor: 1.620

  5 in total
  4 in total

Review 1.  Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.

Authors:  Zoltán Papp; Piergiuseppe Agostoni; Julian Alvarez; Dominique Bettex; Stefan Bouchez; Dulce Brito; Vladimir Černý; Josep Comin-Colet; Marisa G Crespo-Leiro; Juan F Delgado; István Édes; Alexander A Eremenko; Dimitrios Farmakis; Francesco Fedele; Cândida Fonseca; Sonja Fruhwald; Massimo Girardis; Fabio Guarracino; Veli-Pekka Harjola; Matthias Heringlake; Antoine Herpain; Leo M A Heunks; Tryggve Husebye; Višnja Ivancan; Kristjan Karason; Sundeep Kaul; Matti Kivikko; Janek Kubica; Josep Masip; Simon Matskeplishvili; Alexandre Mebazaa; Markku S Nieminen; Fabrizio Oliva; Julius G Papp; John Parissis; Alexander Parkhomenko; Pentti Põder; Gerhard Pölzl; Alexander Reinecke; Sven-Erik Ricksten; Hynek Riha; Alain Rudiger; Toni Sarapohja; Robert H G Schwinger; Wolfgang Toller; Luigi Tritapepe; Carsten Tschöpe; Gerhard Wikström; Dirk von Lewinski; Bojan Vrtovec; Piero Pollesello
Journal:  J Cardiovasc Pharmacol       Date:  2020-07       Impact factor: 3.105

Review 2.  Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.

Authors:  Zoltán Papp; Piergiuseppe Agostoni; Julian Alvarez; Dominique Bettex; Stefan Bouchez; Dulce Brito; Vladimir Černý; Josep Comin-Colet; Marisa G Crespo-Leiro; Juan F Delgado; Istvan Édes; Alexander A Eremenko; Dimitrios Farmakis; Francesco Fedele; Cândida Fonseca; Sonja Fruhwald; Massimo Girardis; Fabio Guarracino; Veli-Pekka Harjola; Matthias Heringlake; Antoine Herpain; Leo Ma Heunks; Tryggve Husebye; Višnja Ivancan; Kristjan Karason; Sundeep Kaul; Matti Kivikko; Janek Kubica; Josep Masip; Simon Matskeplishvili; Alexandre Mebazaa; Markku S Nieminen; Fabrizio Oliva; Julius-Gyula Papp; John Parissis; Alexander Parkhomenko; Pentti Põder; Gerhard Pölzl; Alexander Reinecke; Sven-Erik Ricksten; Hynek Riha; Alain Rudiger; Toni Sarapohja; Robert Hg Schwinger; Wolfgang Toller; Luigi Tritapepe; Carsten Tschöpe; Gerhard Wikström; Dirk von Lewinski; Bojan Vrtovec; Piero Pollesello
Journal:  Card Fail Rev       Date:  2020-07-08

3.  Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice.

Authors:  Fabio Guarracino; Matthias Heringlake; Bernard Cholley; Dominique Bettex; Stefaan Bouchez; Vladimir V Lomivorotov; Angela Rajek; Matti Kivikko; Piero Pollesello
Journal:  J Cardiovasc Pharmacol       Date:  2018-01       Impact factor: 3.105

4.  Prospective Study on the Postoperative Use of Levosimendan After Conventional Heart Valve Replacement.

Authors:  Wei Sheng; Hui Qiao; Zhaozhuo Niu; Tianyi Wang; Haoyou Li; Wenfeng Zhang; Jiantao Wu; Xiao Lv
Journal:  Med Sci Monit       Date:  2021-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.